Johnson & Johnson Talc-Cancer Row: Pharma Co To Pay 5.5 Billion To Settle Its Decade-Long Controversial Lawsuits

Johnson & Johnson Talc-Cancer Row: Pharma Giant To Pay $5.5 Billion To Settle Its Decade-Long Controversial Lawsuits

Credit: AI

Text

Updated Jul 28, 2026 | 02:02 PM IST

SummaryJohnson & Johnson has agreed to settle its decade-long controversial lawsuit that alleged its talc products and baby powder caused ovarian cancer.

End of Article